| CEO: | Peter Collins |
| Executive Chairman: | Jan Groen |
| Senior Independent Director: | Klaas de Boer |
| Non-Executive Dir: | Benjamin Hart , Kim Oreskovic |
| Address: | 10 Nugent Road, Surrey Research Park, Guildford, Surrey, United Kingdom, GU2 7AF |
| Phone: | +44 (0)1483 343434 |
| Website: | http://cellbxhealth.com |
| Sector: | Support(LSE) |
| Index: | FTSE AIM All-Share |
| ISIN: | GB0034330679 |
| Currency | UK Pounds |
| Share Price | 0.95p |
| Change Today | 0.000p |
| % Change | 0.00 % |
| 52 Week High | 12.25 |
| 52 Week Low | 0.90 |
| Volume | 1,522,128 |
| Shares Issued | 1,139.40m |
| Market Cap | £10.82m |
| Beta | 0.02 |
| Value |
|
|---|
| Price Trend |
|
|---|
| Income | ![]() |
|---|
| Growth |
|
|---|
| No dividends found |
| Time | Volume / Share Price |
| 16:21 | 15,056 @ 0.90p |
| 16:06 | 300,000 @ 1.00p |
| 15:34 | 500,000 @ 0.96p |
| 14:55 | 110,934 @ 0.91p |
| 14:54 | 276,987 @ 0.91p |
You are here: research